The Journal of Clinical Pharmacology

Cover image for The Journal of Clinical Pharmacology

April 2010

Volume 50, Issue 4

Pages 370–483

  1. Editorial

    1. Top of page
    2. Editorial
    3. Review
    4. Pharmacokinetics and Pharmacodynamics
    5. Pharmacodynamics
    6. Pharmacokinetics
    7. Drug Interactions
    8. Special Populations
    9. Letter to the Editor
    10. Erratum
  2. Review

    1. Top of page
    2. Editorial
    3. Review
    4. Pharmacokinetics and Pharmacodynamics
    5. Pharmacodynamics
    6. Pharmacokinetics
    7. Drug Interactions
    8. Special Populations
    9. Letter to the Editor
    10. Erratum
  3. Pharmacokinetics and Pharmacodynamics

    1. Top of page
    2. Editorial
    3. Review
    4. Pharmacokinetics and Pharmacodynamics
    5. Pharmacodynamics
    6. Pharmacokinetics
    7. Drug Interactions
    8. Special Populations
    9. Letter to the Editor
    10. Erratum
    1. PhRMA Survey on the Conduct of First-in-Human Clinical Trials Under Exploratory Investigational New Drug Applications (pages 380–391)

      Dr Adel H. Karara, Dr Timi Edeki, Dr James McLeod, Dr Alfred P. Tonelli and Dr John A. Wagner

      Article first published online: 7 MAR 2013 | DOI: 10.1177/0091270009344987

    2. Pharmacokinetics and Pharmacodynamics of LCZ696, a Novel Dual-Acting Angiotensin Receptor—Neprilysin Inhibitor (ARNi) (pages 401–414)

      Dr Jessie Gu, Dr Adele Noe, Dr Priya Chandra, Dr Suliman Al-Fayoumi, Dr Monica Ligueros-Saylan, Dr Ramesh Sarangapani, Dr Suzanne Maahs, Dr Gary Ksander, Dr Dean F. Rigel, Dr Arco Y. Jeng, Dr Tsu-Han Lin, Dr Weiyi Zheng and Dr William P. Dole

      Article first published online: 7 MAR 2013 | DOI: 10.1177/0091270009343932

  4. Pharmacodynamics

    1. Top of page
    2. Editorial
    3. Review
    4. Pharmacokinetics and Pharmacodynamics
    5. Pharmacodynamics
    6. Pharmacokinetics
    7. Drug Interactions
    8. Special Populations
    9. Letter to the Editor
    10. Erratum
    1. Effects of Milnacipran on Cardiac Repolarization in Healthy Participants (pages 422–433)

      Antonia Periclou, Robert H. Palmer, Hongjie Zheng and Charles Lindamood III

      Article first published online: 7 MAR 2013 | DOI: 10.1177/0091270009346059

  5. Pharmacokinetics

    1. Top of page
    2. Editorial
    3. Review
    4. Pharmacokinetics and Pharmacodynamics
    5. Pharmacodynamics
    6. Pharmacokinetics
    7. Drug Interactions
    8. Special Populations
    9. Letter to the Editor
    10. Erratum
    1. Silymarin Ascending Multiple Oral Dosing Phase I Study in Noncirrhotic Patients With Chronic Hepatitis C (pages 434–449)

      Dr Roy L. Hawke, Dr Sarah J. Schrieber, Dr Tedi A. Soule, Dr Zhiming Wen, Dr Philip C. Smith, Dr K. Rajender Reddy, Dr Abdus S. Wahed, Dr Steven H. Belle, Dr Nezam H. Afdhal, Dr Victor J. Navarro, Dr Josh Berman, Dr Qi-Ying Liu, Dr Edward Doo, Dr Michael W. Fried and The SyNCH Trial Group

      Article first published online: 7 MAR 2013 | DOI: 10.1177/0091270009347475

  6. Drug Interactions

    1. Top of page
    2. Editorial
    3. Review
    4. Pharmacokinetics and Pharmacodynamics
    5. Pharmacodynamics
    6. Pharmacokinetics
    7. Drug Interactions
    8. Special Populations
    9. Letter to the Editor
    10. Erratum
    1. Composite Functional Genetic and Comedication CYP2D6 Activity Score in Predicting Tamoxifen Drug Exposure Among Breast Cancer Patients (pages 450–458)

      Dr Silvana Borges, Dr Zeruesenay Desta, Dr Yan Jin, Mr Azzouz Faouzi, Mr Jason D. Robarge, Mr Santosh Philip, Ms Anne Nguyen, Mr Vered Stearns, Mr Daniel Hayes, Mr James M. Rae, Dr Todd C. Skaar, Dr David A. Flockhart and Dr Lang Li

      Article first published online: 7 MAR 2013 | DOI: 10.1177/0091270009359182

    2. No Pharmacokinetic Interaction Between Lacosamide and Carbamazepine in Healthy Volunteers (pages 459–471)

      Dr Willi Cawello, Dr Brunhild Nickel and Dr Andrea Eggert-Formella

      Article first published online: 7 MAR 2013 | DOI: 10.1177/0091270009347675

  7. Special Populations

    1. Top of page
    2. Editorial
    3. Review
    4. Pharmacokinetics and Pharmacodynamics
    5. Pharmacodynamics
    6. Pharmacokinetics
    7. Drug Interactions
    8. Special Populations
    9. Letter to the Editor
    10. Erratum
    1. Pharmacokinetics and Safety of Sunitinib Malate in Subjects With Impaired Renal Function (pages 472–481)

      Reza Khosravan, Melvin Toh, May Garrett, JoAnn La Fargue, Grace Ni, Thomas C. Marbury, Suzanne K. Swan, Norman M. Lunde and Carlo L. Bello

      Article first published online: 7 MAR 2013 | DOI: 10.1177/0091270009347868

  8. Letter to the Editor

    1. Top of page
    2. Editorial
    3. Review
    4. Pharmacokinetics and Pharmacodynamics
    5. Pharmacodynamics
    6. Pharmacokinetics
    7. Drug Interactions
    8. Special Populations
    9. Letter to the Editor
    10. Erratum
    1. Cardiovascular Effects of Ketamine in Sick Patients: Should Physicians Be Concerned? (page 482)

      Maurice Lippmann, Abhishek Karnwal and Inderjeet S. Julka

      Article first published online: 7 MAR 2013 | DOI: 10.1177/0091270009352484

  9. Erratum

    1. Top of page
    2. Editorial
    3. Review
    4. Pharmacokinetics and Pharmacodynamics
    5. Pharmacodynamics
    6. Pharmacokinetics
    7. Drug Interactions
    8. Special Populations
    9. Letter to the Editor
    10. Erratum
    1. You have free access to this content
      Erratum (page 483)

      Article first published online: 7 MAR 2013 | DOI: 10.1177/0091270010366151

SEARCH

SEARCH BY CITATION